Macrogenics (MGNX) Net Cash Flow (2012 - 2026)

Macrogenics (MGNX) has 15 years of Net Cash Flow data on file, last reported at $9.3 million in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 124.95% year-over-year to $9.3 million in Q1 2026; TTM through Mar 2026 was -$79.1 million, a 221.22% decrease from a year earlier, with the FY2025 full-year figure at -$125.6 million, down 253.42% from the prior year.
• Net Cash Flow for Q1 2026 stood at $9.3 million, up from -$22.9 million in the prior quarter.
• Over the last five years, Net Cash Flow for MGNX reached as high as $115.4 million in Q1 2023 and fell as low as -$115.5 million in Q2 2023.
• Historically, Net Cash Flow has averaged -$3.4 million across 5 years, with a median of -$14.9 million in 2025.
• Across the five-year window, Net Cash Flow soared 3905.38% in 2022 and plunged 812.66% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $24.9 million in 2022, then sank by 55.57% to $11.1 million in 2023, then plunged by 70.93% to $3.2 million in 2024, then plunged by 812.66% to -$22.9 million in 2025, then jumped by 140.59% to $9.3 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $9.3 million in Q1 2026, -$22.9 million in Q4 2025, and -$50.6 million in Q3 2025.